Nature Communications (Jan 2018)

GLP-1 release and vagal afferent activation mediate the beneficial metabolic and chronotherapeutic effects of D-allulose

  • Yusaku Iwasaki,
  • Mio Sendo,
  • Katsuya Dezaki,
  • Tohru Hira,
  • Takehiro Sato,
  • Masanori Nakata,
  • Chayon Goswami,
  • Ryohei Aoki,
  • Takeshi Arai,
  • Parmila Kumari,
  • Masaki Hayakawa,
  • Chiaki Masuda,
  • Takashi Okada,
  • Hiroshi Hara,
  • Daniel J. Drucker,
  • Yuichiro Yamada,
  • Masaaki Tokuda,
  • Toshihiko Yada

DOI
https://doi.org/10.1038/s41467-017-02488-y
Journal volume & issue
Vol. 9, no. 1
pp. 1 – 17

Abstract

Read online

The sweetener D-allulose has beneficial metabolic effects in animal models, but its mechanism of action was unclear. Here the authors report that D-allulose triggers GLP-1 release in the gut and GLP-1R signaling on vagal afferents, counteracting arrhythmic overeating, obesity and diabetes.